Financhill
Sell
44

INSP Quote, Financials, Valuation and Earnings

Last price:
$80.82
Seasonality move :
2.18%
Day range:
$94.81 - $97.04
52-week range:
$70.77 - $203.12
Dividend yield:
0%
P/E ratio:
65.99x
P/S ratio:
3.27x
P/B ratio:
4.19x
Volume:
596.9K
Avg. volume:
1.6M
1-year change:
-48.03%
Market cap:
$2.8B
Revenue:
$802.8M
EPS (TTM):
$1.46

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
INSP
Inspire Medical Systems, Inc.
$265.3M $0.68 6.51% 11.45% $135.69
AVTR
Avantor, Inc.
$1.6B $0.22 -0.43% 115.56% $13.04
ELMD
Electromed, Inc.
$18M -- 11.04% -- $36.00
IRIX
IRIDEX Corp.
$12.8M -$0.12 -2.72% -18.18% --
MYO
Myomo, Inc.
$10.4M -$0.09 -13.8% -1168.66% $5.00
STXS
Stereotaxis, Inc.
$9.2M -$0.07 22.79% -21.32% $4.20
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
INSP
Inspire Medical Systems, Inc.
$96.20 $135.69 $2.8B 65.99x $0.00 0% 3.27x
AVTR
Avantor, Inc.
$12.21 $13.04 $8.3B 10.97x $0.00 0% 1.27x
ELMD
Electromed, Inc.
$27.50 $36.00 $229.4M 29.59x $0.00 0% 3.67x
IRIX
IRIDEX Corp.
$1.56 -- $26.8M -- $0.00 0% 0.52x
MYO
Myomo, Inc.
$0.97 $5.00 $37.4M -- $0.00 0% 0.96x
STXS
Stereotaxis, Inc.
$2.75 $4.20 $256.6M -- $0.00 0% 8.11x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
INSP
Inspire Medical Systems, Inc.
4.66% -0.753 1.51% 3.89x
AVTR
Avantor, Inc.
40.92% 1.212 45.33% 0.90x
ELMD
Electromed, Inc.
-- 1.105 -- 4.58x
IRIX
IRIDEX Corp.
50.55% 0.557 18.81% 1.03x
MYO
Myomo, Inc.
45.68% -2.417 35.87% 1.94x
STXS
Stereotaxis, Inc.
32.62% 1.932 1.93% 0.81x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
INSP
Inspire Medical Systems, Inc.
$192.7M $9.6M 6.32% 6.62% 4.3% $58.1M
AVTR
Avantor, Inc.
$526.5M $138.4M -0.81% -1.4% 8.52% $171.7M
ELMD
Electromed, Inc.
$13.2M $2.7M 18.88% 18.89% 15.81% -$98K
IRIX
IRIDEX Corp.
$4M -$1.4M -54.1% -155.93% -11.3% -$1.2M
MYO
Myomo, Inc.
$6.4M -$3.5M -46.49% -68.35% -34.86% -$2.9M
STXS
Stereotaxis, Inc.
$4.1M -$5.2M -141.59% -218.3% -69.75% -$4.2M

Inspire Medical Systems, Inc. vs. Competitors

  • Which has Higher Returns INSP or AVTR?

    Avantor, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of -43.84%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Avantor, Inc.'s return on equity of -1.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems, Inc.
    85.85% $0.34 $699M
    AVTR
    Avantor, Inc.
    32.42% -$1.04 $9.4B
  • What do Analysts Say About INSP or AVTR?

    Inspire Medical Systems, Inc. has a consensus price target of $135.69, signalling upside risk potential of 41.05%. On the other hand Avantor, Inc. has an analysts' consensus of $13.04 which suggests that it could grow by 6.76%. Given that Inspire Medical Systems, Inc. has higher upside potential than Avantor, Inc., analysts believe Inspire Medical Systems, Inc. is more attractive than Avantor, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems, Inc.
    9 6 0
    AVTR
    Avantor, Inc.
    3 14 1
  • Is INSP or AVTR More Risky?

    Inspire Medical Systems, Inc. has a beta of 0.725, which suggesting that the stock is 27.474% less volatile than S&P 500. In comparison Avantor, Inc. has a beta of 0.926, suggesting its less volatile than the S&P 500 by 7.414%.

  • Which is a Better Dividend Stock INSP or AVTR?

    Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Avantor, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Avantor, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or AVTR?

    Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are smaller than Avantor, Inc. quarterly revenues of $1.6B. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Avantor, Inc.'s net income of -$711.8M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 65.99x while Avantor, Inc.'s PE ratio is 10.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 3.27x versus 1.27x for Avantor, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems, Inc.
    3.27x 65.99x $224.5M $9.9M
    AVTR
    Avantor, Inc.
    1.27x 10.97x $1.6B -$711.8M
  • Which has Higher Returns INSP or ELMD?

    Electromed, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of 12.65%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Electromed, Inc.'s return on equity of 18.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems, Inc.
    85.85% $0.34 $699M
    ELMD
    Electromed, Inc.
    78.15% $0.25 $44.7M
  • What do Analysts Say About INSP or ELMD?

    Inspire Medical Systems, Inc. has a consensus price target of $135.69, signalling upside risk potential of 41.05%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 30.91%. Given that Inspire Medical Systems, Inc. has higher upside potential than Electromed, Inc., analysts believe Inspire Medical Systems, Inc. is more attractive than Electromed, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems, Inc.
    9 6 0
    ELMD
    Electromed, Inc.
    4 0 0
  • Is INSP or ELMD More Risky?

    Inspire Medical Systems, Inc. has a beta of 0.725, which suggesting that the stock is 27.474% less volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.266, suggesting its less volatile than the S&P 500 by 73.442%.

  • Which is a Better Dividend Stock INSP or ELMD?

    Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or ELMD?

    Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Electromed, Inc.'s net income of $2.1M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 65.99x while Electromed, Inc.'s PE ratio is 29.59x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 3.27x versus 3.67x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems, Inc.
    3.27x 65.99x $224.5M $9.9M
    ELMD
    Electromed, Inc.
    3.67x 29.59x $16.9M $2.1M
  • Which has Higher Returns INSP or IRIX?

    IRIDEX Corp. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of -12.6%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat IRIDEX Corp.'s return on equity of -155.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems, Inc.
    85.85% $0.34 $699M
    IRIX
    IRIDEX Corp.
    32.15% -$0.09 $9.5M
  • What do Analysts Say About INSP or IRIX?

    Inspire Medical Systems, Inc. has a consensus price target of $135.69, signalling upside risk potential of 41.05%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 28.21%. Given that Inspire Medical Systems, Inc. has higher upside potential than IRIDEX Corp., analysts believe Inspire Medical Systems, Inc. is more attractive than IRIDEX Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems, Inc.
    9 6 0
    IRIX
    IRIDEX Corp.
    0 0 0
  • Is INSP or IRIX More Risky?

    Inspire Medical Systems, Inc. has a beta of 0.725, which suggesting that the stock is 27.474% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.142%.

  • Which is a Better Dividend Stock INSP or IRIX?

    Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or IRIX?

    Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 65.99x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 3.27x versus 0.52x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems, Inc.
    3.27x 65.99x $224.5M $9.9M
    IRIX
    IRIDEX Corp.
    0.52x -- $12.5M -$1.6M
  • Which has Higher Returns INSP or MYO?

    Myomo, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of -36.3%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Myomo, Inc.'s return on equity of -68.35%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems, Inc.
    85.85% $0.34 $699M
    MYO
    Myomo, Inc.
    63.84% -$0.09 $26.9M
  • What do Analysts Say About INSP or MYO?

    Inspire Medical Systems, Inc. has a consensus price target of $135.69, signalling upside risk potential of 41.05%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 413.45%. Given that Myomo, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Myomo, Inc. is more attractive than Inspire Medical Systems, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems, Inc.
    9 6 0
    MYO
    Myomo, Inc.
    4 0 0
  • Is INSP or MYO More Risky?

    Inspire Medical Systems, Inc. has a beta of 0.725, which suggesting that the stock is 27.474% less volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.052, suggesting its more volatile than the S&P 500 by 5.158%.

  • Which is a Better Dividend Stock INSP or MYO?

    Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or MYO?

    Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 65.99x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 3.27x versus 0.96x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems, Inc.
    3.27x 65.99x $224.5M $9.9M
    MYO
    Myomo, Inc.
    0.96x -- $10.1M -$3.7M
  • Which has Higher Returns INSP or STXS?

    Stereotaxis, Inc. has a net margin of 4.42% compared to Inspire Medical Systems, Inc.'s net margin of -86.59%. Inspire Medical Systems, Inc.'s return on equity of 6.62% beat Stereotaxis, Inc.'s return on equity of -218.3%.

    Company Gross Margin Earnings Per Share Invested Capital
    INSP
    Inspire Medical Systems, Inc.
    85.85% $0.34 $699M
    STXS
    Stereotaxis, Inc.
    54.94% -$0.07 $17.1M
  • What do Analysts Say About INSP or STXS?

    Inspire Medical Systems, Inc. has a consensus price target of $135.69, signalling upside risk potential of 41.05%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 52.73%. Given that Stereotaxis, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Stereotaxis, Inc. is more attractive than Inspire Medical Systems, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    INSP
    Inspire Medical Systems, Inc.
    9 6 0
    STXS
    Stereotaxis, Inc.
    3 0 0
  • Is INSP or STXS More Risky?

    Inspire Medical Systems, Inc. has a beta of 0.725, which suggesting that the stock is 27.474% less volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.445, suggesting its more volatile than the S&P 500 by 44.465%.

  • Which is a Better Dividend Stock INSP or STXS?

    Inspire Medical Systems, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Inspire Medical Systems, Inc. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios INSP or STXS?

    Inspire Medical Systems, Inc. quarterly revenues are $224.5M, which are larger than Stereotaxis, Inc. quarterly revenues of $7.5M. Inspire Medical Systems, Inc.'s net income of $9.9M is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, Inspire Medical Systems, Inc.'s price-to-earnings ratio is 65.99x while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Inspire Medical Systems, Inc. is 3.27x versus 8.11x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    INSP
    Inspire Medical Systems, Inc.
    3.27x 65.99x $224.5M $9.9M
    STXS
    Stereotaxis, Inc.
    8.11x -- $7.5M -$6.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 62x

Sell
47
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Sell
27
RGC alert for Jan 22

Regencell Bioscience Holdings Ltd. [RGC] is up 40.39% over the past day.

Buy
62
BNR alert for Jan 22

Burning Rock Biotech Ltd. [BNR] is up 33.29% over the past day.

Buy
71
HYMC alert for Jan 22

Hycroft Mining Holding Corp. [HYMC] is up 17.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock